El cáncer de próstata metastásico se presenta en el 20% de pacientes al momento del
diagnóstico de cáncer de próstata (1). Los sitios comunes de diseminación metastásica
locorregional son los ganglios linfáticos (99%) y huesos como pelvis, cadera y esqueleto axial
(84%); mientras que las localiz...
This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully into account, and specifically any special arrangements relating to the introduction of new inter...
This evaluation uses new cost-effectiveness estimates to update olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer (NICE technology appraisal guidance TA831). No new clinical evidence was reviewed. Treatments for BRCA mutation-positive hormone-relapsed meta...
Evidence-based recommendations on olaparib (Lynparza) for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer in adults.
Commercial arrangement
There is a simple discount patient access scheme for olaparib. NHS organisations can get details on the Commercial Access and ...
Evidence-based recommendations on biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer. This involves pushing the rectum slightly away from the prostate by inserting a balloon or injecting a gel (spacer) between them....
El cáncer de próstata es producto de una proliferación descontrolada de células glandulares,
ductales u otras de la glándula prostática. El tipo histológico más frecuente es el
adenocarcinoma y se ubican principalmente en la zona periférica de la próstata (1). Así mismo,
esta neoplasia se pued...
When dealing with patients with prostate cancer, healthcare professionals should pay particular attention to the
patient’s psychological well-being and actively ask about this. Healthcare professionals should also pay particular
attention to whether the patient shows depressive symptoms....
A clinical summary of this KDP was published in the Journal of the Ministry of Health of the Czech Republic .
Prostate cancer is one of the most common oncological diseases in men, and its incidence in the Czech Republic has almost tripled over the past twenty years. At the same time, the number of dea...
Generar recomendaciones basadas en la mejor evidencia disponible, en relación con el manejo de personas mayores de 15 años con Cáncer de Próstata....
Generar recomendaciones basadas en la mejor evidencia disponible acerca del manejo de hombres con crecimiento prostático benigno sintomático. Hombres con crecimiento prostático benigno sintomático que
reciben atención en el nivel secundario y terciario de salud en el sector público y privado de sal...
